4//SEC Filing
KENSEY NASH CORP 4
Accession 0001104659-12-045611
CIK 0001002811operating
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:47 PM ET
Size
6.0 KB
Accession
0001104659-12-045611
Insider Transaction Report
Form 4
KENSEY NASH CORPKNSY
Royal DSM N.V.
10% Owner
Transactions
- Purchase
Common Stock
2012-06-22$38.50/sh+7,953,922$306,225,997→ 15,061,177 total(indirect: See Explanation of Responses)
Footnotes (2)
- [F1]The Reporting Person is filing this Form 4 on behalf of itself and on behalf of Biomedical Acquisition Corporation ("Biomedical"), formerly a Delaware corporation and an indirect wholly owned subsidiary of the Reporting Person, with principal executive offices located at 45 Waterview Blvd., Parsippany, NJ 07054. The shares of common stock to which this Form 4 relates were acquired by Biomedical directly from the Issuer pursuant to an agreement and plan of merger, dated as of May 2, 2012, among the Issuer, the Reporting Person and Biomedical, following the expiration of a tender offer for all outstanding shares of common stock of the Issuer, upon the terms and subject to the conditions set forth in the Offer to Purchase dated May 21, 2012, which was annexed to and filed with the Schedule TO filed by the Reporting Person with the Securities and Exchange Commission on May 21, 2012.
- [F2]Following the acquisition of shares as reported herein, Biomedical was merged with and into the Issuer and the shares reported herein were canceled.
Documents
Issuer
KENSEY NASH CORP
CIK 0001002811
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001002811
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 6:47 PM ET
- Size
- 6.0 KB